Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Articles and issues > Author index
Search
Ji Young Park 5 Articles
Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection
Jinhee Kim, Moonsik Kim, Ji Young Park
J Pathol Transl Med. 2022;56(5):289-293.   Published online September 13, 2022
DOI: https://doi.org/10.4132/jptm.2022.08.02
  • 2,583 View
  • 90 Download
  • 3 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary Material
Background
Human papillomavirus (HPV) infection is a major cause of cervical cancer and associated precursor lesions. Multiple HPV genotype infections have been reported. However, their clinicopathological characteristics still remain elusive.
Methods
For this study, 814 consecutive patients who had undergone colposcopy and HPV genotyping test using BD Onclarity HPV assay were retrospectively selected. Clinicopathological parameters of multiple HPV infections were compared with those of single HPV infection.
Results
Multiple HPV infections were found in 110 out of 814 cases (13.5%). Multiple HPV infections were associated with a significantly higher incidence of high-grade intraepithelial lesions (HSILs) compared with single HPV infection. Other high-risk HPV genotypes, in addition to HPV 16, were found more frequently in the multiple HPV infections group; these included HPV 51, 52, 33/58, 56/59/66, and 35/39/68. No specific coinfection pattern was not identified. Additionally, the number of HPV genotypes in multiple HPV infections was not associated with the progression to HSIL or squamous cell carcinoma.
Conclusions
Multiple HPV infections have distinct clinicopathological characteristics (compared with single HPV infection). As their biological behavior is uncertain, close and frequent follow-up is warranted.

Citations

Citations to this article as recorded by  
  • Relative distribution of HPV genotypes in histological cervical samples and associated grade lesion in a women population over the last 16 years in Burgundy, France
    Christelle Auvray, Serge Douvier, Odile Caritey, Jean-Baptiste Bour, Catherine Manoha
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Epidemiologic characteristics of high-risk HPV and the correlation between multiple infections and cervical lesions
    Qinli Luo, Xianghua Zeng, Hanyi Luo, Ling Pan, Ying Huang, Haiyan Zhang, Na Han
    BMC Infectious Diseases.2023;[Epub]     CrossRef
IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma
Ji Young Park, Misun Choe, Yuna Kang, Sang Sook Lee
Korean J Pathol. 2014;48(2):108-116.   Published online April 28, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.2.108
  • 6,937 View
  • 32 Download
  • 4 Crossref
AbstractAbstract PDF
Background

Insulin-like growth factor II mRNA-binding protein 3 (IMP3) has been reported as a prognostic biomarker in various cancers. To validate IMP3 as a prognostic biomarker in renal cell carcinoma (RCC), we investigated the expression of IMP3, p53, and Ki-67, and their associations with clinicopathologic outcomes.

Methods

We studied 148 clear cell RCCs (CCRCCs) from patients who underwent radical nephrectomy. The expression levels of IMP3, p53, and Ki-67 were assessed by immunohistochemical staining and the clinical and pathologic parameters were retrospectively reviewed.

Results

Twenty-nine percent of CCRCCs expressed IMP3. Forty-one percent of IMP3-immunopositive tumors developed metastases, while only 11.4% of IMP3-negative tumors developed metastases (p<.001). A Kaplan-Meier curve showed that patients with IMP3-immunopositive tumors had lower metastasis-free survival and cancer-specific survival than did those with IMP3-immunonegative tumors (p<.001 and p<.001, respectively). Expression of high Ki-67 proliferation index was also associated with a higher metastatic rate. In the multivariate Cox regression analysis, pT stage and IMP3-positivity were independently associated with disease-specific survival.

Conclusions

IMP3 is an independent prognostic biomarker for patients with CCRCC to predict metastasis and poor outcome.

Citations

Citations to this article as recorded by  
  • IMP3 Immunohistochemical Expression Is Related with Progression and Metastases in Xenografted and Cutaneous Melanomas
    Natividad Martin-Morales, Miguel Padial-Molina, Isabel Tovar, Virginea De Araujo Farias, Pedro Hernández-Cortés, Esperanza Ramirez-Moreno, Mercedes Caba-Molina, Justin Davis, Alejandro Carrero Castaño, Jose Mariano Ruiz de Almodovar, Pablo Galindo-Moreno,
    Pathobiology.2024; 91(2): 132.     CrossRef
  • circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma
    Yuenan Liu, Kailei Chen, Yi Shou, Sen Li, Jun Wang, Qingyang Zhang, Ziwei Huang, Jiaju Xu, Mingfeng Li, Di Liu, Huageng Liang, Hongmei Yang, Xiaoping Zhang
    Clinical and Translational Medicine.2023;[Epub]     CrossRef
  • Prognostic value of insulin‑like growth factor 2 mRNA‑binding protein 3 and vascular endothelial growth factor‑A in patients with primary non‑small‑cell lung cancer
    Jiannan Liu, Ying Liu, Wenjing Gong, Xiangshuo Kong, Congcong Wang, Shuhua Wang, Aina Liu
    Oncology Letters.2019;[Epub]     CrossRef
  • Epithelial‑mesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3
    Shuping You, Yun Guan, Weihong Li
    Molecular Medicine Reports.2017;[Epub]     CrossRef
MAD2 Expression in Ovarian Carcinoma: Different Expression Patterns and Levels among Various Types of Ovarian Carcinoma and Its Prognostic Significance in High-Grade Serous Carcinoma
Po Eun Park, Ji Yun Jeong, Sun Zoo Kim, Ji Young Park
Korean J Pathol. 2013;47(5):418-425.   Published online October 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.5.418
  • 5,951 View
  • 33 Download
  • 5 Crossref
AbstractAbstract PDF
Background

Mitotic arrest deficiency protein 2 (MAD2) is a key component of spindle assembly checkpoint function, which mediates cell apoptosis through microtubule kinetics. Aberrant expression of MAD2 is believed to be associated with the development of chromosome instability. MAD2 also has a signihicant role in cellular drug resistance to taxane chemotherapeutic agents.

Methods

Expression of MAD2 and p53 was investigated using immunohistochemistry in 85 cases of ovarian carcinomas. Clinicopathological data including progression-free survival were analyzed.

Results

A significant (p=.035) association was observed between the grade of serous carcinoma and the expression level of MAD2. While low-grade serous carcinoma showed a low-level expression of MAD2, high-grade serous carcinoma showed a high-level expression of MAD2. We also determined that low-level expression of MAD2 was associated with reduced progression-free survival (PFS) (p=.016) in high-grade serous carcinoma.

Conclusions

MAD2 expression in ovarian carcinoma is related to the grade of serous carcinoma and PFS of high-grade serous carcinoma. Expression level of MAD2 detected by immunohistochemistry may serve as an indicator in predicting the response of microtubule-interfering chemotherapeutic agents.

Citations

Citations to this article as recorded by  
  • The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer
    Mark Bates, Cathy D. Spillane, Michael F. Gallagher, Amanda McCann, Cara Martin, Gordon Blackshields, Helen Keegan, Luke Gubbins, Robert Brooks, Doug Brooks, Stavros Selemidis, Sharon O’Toole, John J. O’Leary, David Wai Chan
    PLOS ONE.2020; 15(12): e0243715.     CrossRef
  • Aneuploidy: Cancer strength or vulnerability?
    Giorgia Simonetti, Samantha Bruno, Antonella Padella, Elena Tenti, Giovanni Martinelli
    International Journal of Cancer.2019; 144(1): 8.     CrossRef
  • The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses
    Tara Byrne, Helen G. Coleman, Janine A. Cooper, W. Glenn McCluggage, Amanda McCann, Fiona Furlong
    Oncotarget.2017; 8(60): 102223.     CrossRef
  • Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis
    L Yang, S Feng, Y Yang
    Cancer Gene Therapy.2016; 23(12): 439.     CrossRef
  • Proteins of the mitotic checkpoint and spindle are related to chromosomal instability and unfavourable prognosis in patients with myelodysplastic syndrome
    Kelly Roveran Genga, Francisco Dário Rocha Filho, Francisco Valdeci de Almeida Ferreira, Juliana Cordeiro de Sousa, Fernando Sergio Studart, Silvia Maria Meira Magalhães, Fabíola Fernandes Heredia, Ronald Feitosa Pinheiro
    Journal of Clinical Pathology.2015; 68(5): 381.     CrossRef
Fine-Needle Aspiration Cytology of Low-Grade Cribriform Cystadenocarcinoma with Many Psammoma Bodies of the Salivary Gland
Ji Yun Jeong, Dongbin Ahn, Ji Young Park
Korean J Pathol. 2013;47(5):481-485.   Published online October 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.5.481
  • 6,317 View
  • 38 Download
  • 12 Crossref
AbstractAbstract PDF

Low-grade cribriform cystadenocarcinoma (LGCCC) is a rare salivary gland tumor that was recently defined as a variant of cystadenocarcinoma by the 2005 World Health Orgazniation (WHO) classification system. We report cytologic findings of an unusual case of LGCCC with many psammoma bodies. A 90-year-old man presented a palpable mass on his left parotid gland. Fine-needle aspiration (FNA) cytology showed tumor cells that were arranged in clusters and dispersed individually. The tumor cells showed mild atypia and had clear or dense cytoplasm with some vacuoles. Numerous psammoma bodies were noted. After surgical resection, the histologic examination revealed a mixed solid and cystic mass showing intraductal growth with focal stromal invasion. The S-100 protein expressed in the tumor cells, but smooth muscle actin and p63 were positive only in myoepithelial cells. Although LGCCCs resemble other salivary gland tumors, differentiating LGCCC during preoperative FNA is important to avoid unnecessary overtreatment.

Citations

Citations to this article as recorded by  
  • Salivary Gland Intraductal Carcinoma: How Do 183 Reported Cases Fit Into a Developing Classification
    Lester D.R. Thompson, Justin A. Bishop
    Advances in Anatomic Pathology.2023; 30(2): 112.     CrossRef
  • Duct tales of a parotid gland swelling
    Swati Raj, Monika Singh, Mamta Gupta, Naveen Thapliyal
    Cytojournal.2023; 20: 22.     CrossRef
  • Intraductal carcinoma of the parotid gland
    Yukiya HIRATA, Kayoko HIGUCHI, Toshitaka NAGAO, Yoko ZUKERAN, Takao KINJO, Naoki WADA
    The Journal of the Japanese Society of Clinical Cytology.2022; 61(6): 431.     CrossRef
  • Intraductal carcinoma of the retromolar trigone found with elevated serum CEA and CA19-9 levels: a case report
    Mao KAWAKAMI, Nobuhiro UEDA, Yuka TAKAHASHI, Sho ARIKAWA, Nobuhiro YAMAKAWA, Tadaaki KIRITA
    Japanese Journal of Oral and Maxillofacial Surgery.2021; 67(5): 292.     CrossRef
  • Endoscopic trans‐pterygoid resection of a low‐grade cribriform cystadenocarcinoma of the infratemporal fossa
    Vikram G. Ramjee, Landon J. Massoth, John P. Richards, Kibwei A. McKinney
    World Journal of Otorhinolaryngology - Head and Neck Surgery.2020; 6(2): 115.     CrossRef
  • Psammoma Bodies in a Large Myoepithelioma
    Marcela Pessoa de Melo, Diego Filipe Bezerra Silva, Rodrigo Alves Ribeiro, Tony Santos Peixoto, Daliana Queiroga de Castro Gomes, Pollianna Muniz Alves, Cassiano Francisco Weege Nonaka, Bárbara Vanessa de Brito Monteiro
    Journal of Craniofacial Surgery.2020; 31(4): e326.     CrossRef
  • Low-grade intraductal carcinoma of salivary glands: A systematic review of this rare entity
    Francesco Giovacchini, Caterina Bensi, Stefano Belli, Maria Elena Laurenti, Martina Mandarano, Daniele Paradiso, Michele Giansanti, Antonio Tullio
    Journal of Oral Biology and Craniofacial Research.2019; 9(1): 96.     CrossRef
  • What is your diagnosis? Submandibular mass in a dog
    Julie Allen, Ashley M. Talley, Carol B. Grindem, Jennifer A. Neel
    Veterinary Clinical Pathology.2018; 47(4): 676.     CrossRef
  • Primary acinic cell carcinoma of the lung with psammoma bodies: A case report and review of literature
    Xiu-Peng Zhang, Gui-Yang Jiang, Qing-Fu Zhang, Hong-Tao Xu, Qing-Chang Li, En-Hua Wang
    Pathology - Research and Practice.2017; 213(4): 405.     CrossRef
  • Cytology of low‐grade cribriform cystadenocarcinoma in salivary glands: Cytological and immunohistochemical distinctions from other salivary gland neoplasms
    Yoshiki Ohta, Yuko Hirota, Yohko Kohno, Koji Kishimoto, Tomoko Norose, Nobuyuki Ohike, Masafumi Takimoto, Akira Shiokawa, Hidekazu Ota
    Diagnostic Cytopathology.2016; 44(3): 241.     CrossRef
  • Low-grade cribriform cystadenocarcinoma arising from a minor salivary gland: a case report
    Masashi Kimura, Shinji Mii, Shinichi Sugimoto, Kosuke Saida, Shojiroh Morinaga, Masahiro Umemura
    Journal of Oral Science.2016; 58(1): 145.     CrossRef
  • A Case of Cystadenocarcinoma Arising from Parotid Gland
    Jong Chul Hong, Tae Kyoung Koh, Min Gyoung Pak, Heon Soo Park
    Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2016; 59(4): 300.     CrossRef
A Soft Tissue Perineurioma and a Hybrid Tumor of Perineurioma and Schwannoma
Ji Young Park, Nam Jo Park, Sang Pyo Kim, Kun Young Kwon, Sang Sook Lee
Korean J Pathol. 2012;46(1):75-78.   Published online February 23, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.1.75
  • 6,867 View
  • 54 Download
  • 14 Crossref
AbstractAbstract PDF

Perineuriomas are composed of differentiated perineurial cells. Perineuriomas have been recently recognized by the immunoreactivity for epithelial membrane antigen (EMA). Microscopically, perineuriomas show proliferation of spindle cells with wavy nuclei and delicate elongated bipolar cytoplasmic processes. The tumor cells are usually negative for the S-100 protein. Ultrastructurally, perineurial cells reveal slender, nontapered processes containing pinocytic vesicles and discontinuous basal lamina. Interestingly, hybrid tumors of benign peripheral nerve sheath tumor (PNST) have been recently reported by using immunohistochemical and ultrastructural investigations. Herein, we report a case of soft tissue perineurioma arising in the skin of a 56-year-old female; another case of a hybrid tumor of perineurioma and schwannoma in the posterior mediastinum occurred in a 53-year-old male, which is the first case of the hybrid PNST tumor reported in Korea.

Citations

Citations to this article as recorded by  
  • Neurogenic tumours of the posterior mediastinum and differential diagnosis considerations
    Michael A den Bakker, Annikka Weissferdt
    Histopathology.2024; 84(1): 238.     CrossRef
  • Hybrid tumors with perineurioma components: a systematic review of the literature and illustrative case
    Karina A. Lenartowicz, Dileep D. Monie, Kimberly K. Amrami, Christopher J. Klein, Caterina Giannini, Robert J. Spinner
    Acta Neurochirurgica.2022; 165(4): 935.     CrossRef
  • Hybrid Schwannoma/Perineurioma: Morphologic Variations and Genetic Profiles
    Takanori Hirose, Anna Kobayashi, Sumihito Nobusawa, Naoe Jimbo
    Applied Immunohistochemistry & Molecular Morphology.2021; 29(6): 433.     CrossRef
  • Mesenchymal Tumors of the Mediastinum: An Update on Diagnostic Approach
    Joon Hyuk Choi, Jae Y. Ro
    Advances in Anatomic Pathology.2021; 28(5): 351.     CrossRef
  • Neurogenic Tumors of the Mediastinum
    Erika F. Rodriguez, Robert Jones, Daniel Miller, Fausto J. Rodriguez
    Seminars in Diagnostic Pathology.2020; 37(4): 179.     CrossRef
  • A Rare Perineurioma/Granular Cell Tumor Hybrid Peripheral Nerve Sheath Tumor
    Koorosh Haghayeghi, Gladys Telang, Sonja Chen, Jack Bevivino, Shamlal Mangray, Yiang Hui, Leslie Robinson-Bostom
    The American Journal of Dermatopathology.2020; 42(10): 762.     CrossRef
  • Hybrid peripheral nerve sheath tumors
    Emine KILIÇ BAĞIR, Arbil AÇIKALIN, Gülfiliz GÖNLÜŞEN, Suzan ZORLUDEMİR, Mehmet Ali DEVECİ
    Cukurova Medical Journal.2019; 44(3): 804.     CrossRef
  • Primary intraosseous hybrid epithelioid schwannoma/perineurioma in the proximal tibia: a case report of benign hybrid neoplasm with local hypercellularity
    Yuejiao Lang, Dawei Liu, Pei Xiang, Jilin Wang, Yang Li
    Diagnostic Pathology.2019;[Epub]     CrossRef
  • Hybrid peripheral nerve sheath tumors: report of five cases and detailed review of literature
    Nasir Ud Din, Zubair Ahmad, Jamshid Abdul-Ghafar, Rashida Ahmed
    BMC Cancer.2017;[Epub]     CrossRef
  • Primary intraosseous hybrid nerve sheath tumor of femur: A hitherto undescribed occurrence in bone with secondary aneurysmal bone cyst formation resulting in pathological fracture
    Louis Tsun Cheung Chow
    Pathology - Research and Practice.2015; 211(5): 409.     CrossRef
  • Mesenchymal tumours of the mediastinum—part II
    Michael A. den Bakker, Alexander Marx, Kiyoshi Mukai, Philipp Ströbel
    Virchows Archiv.2015; 467(5): 501.     CrossRef
  • Primary pleural hybrid cellular schwannoma/perineurioma: A case report
    Danny Soria-Céspedes, Carlos Robles-Vidal, Arturo Gómez-González, Rosalinda Peñaloza-Ramírez, Carlos Ortiz-Hidalgo
    Respiratory Investigation.2014; 52(4): 269.     CrossRef
  • Hybrid peripheral nerve sheath tumour with intermingled perineuriomatous and schwannomatous areas reflected in skin ultrasonography image
    H. Saeki, K. Ito, Y. Nobeyama, T. Ishiji, M. Fukunaga, H. Nakagawa
    Clinical and Experimental Dermatology.2014; 39(6): 747.     CrossRef
  • Périneuriome extraneural des tissus mous localisé au nez
    A. Zaouak, R. Benmously, M. Belhadj Salah, W. Koubaa, A. Debbiche, I. Mokhtar
    Annales de Dermatologie et de Vénéréologie.2013; 140(8-9): 540.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine